[Dermatomyositis and polymyositis]

Area of Science:

• Immunology
• Neurology
• Rheumatology

Context:

• Idiopathic inflammatory myopathies (IIMs) encompass dermatomyositis (DM) and polymyositis (PM).
• Both conditions share proximal muscle weakness but differ in clinical presentations.
• DM is characterized by skin manifestations, juvenile forms, and a higher incidence of malignancies.

Purpose:

• To review the clinical characteristics, diagnostic markers, genetic predispositions, and pathophysiological mechanisms of DM and PM.
• To highlight the role of creatine kinase monitoring and antibody titers, particularly anti-Jo-1 antibodies.
• To elucidate the immune-mediated pathways involved in muscle fiber damage and endothelial cell lysis.

Summary:

• Creatine kinase monitoring is crucial, though levels can be normal. Anti-Jo-1 antibodies are linked to interstitial lung disease and poor prognosis.
• Genetic predisposition involves HLA haplotypes, suggesting a dysimmune response.
• Pathological mechanisms include humoral immunity in DM and CD8+ T-cell aggression in PM, with complex interactions of cytokines and immune molecules.

Impact:

• Understanding the distinct features and underlying pathophysiology of DM and PM aids in diagnosis and management.
• Identifies key biomarkers and genetic factors contributing to disease development.
• Highlights the need for further research into causal antigens and triggers for endothelial cell lysis and muscle fiber cytotoxicity.